Paper9479280
Increased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma.
Tripathi RC and 4 others. Ophthalmology, 1998. Cited by 204 papers, by iCite.
Cite this record
ConductScience Library. Increased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma. Papers, record 9479280. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9479280
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Increased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aqueous Humor | Major topic |
| Endothelial Growth Factors | Major topic |
| Glaucoma, Neovascular | Major topic |
| Lymphokines | Major topic |
| Aged | |
| Aged, 80 and over | |
| Cataract | |
| Enzyme-Linked Immunosorbent Assay | |
| Glaucoma, Open-Angle | |
| Humans | |
| Iris | |
| Middle Aged | |
| Neovascularization, Pathologic | |
| Vascular Endothelial Growth Factor A | |
| Vascular Endothelial Growth Factors |
Source PubMed
Cited by76
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 204 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42818326 | VEGFA-Positive Macrophages Regulate Aqueous Humor Outflow in Aged Mice and Humans. | bioRxiv | 2026 | https://conductscience.org/library/papers/42818326 | PubMed |
| 42317267 | Vascular regeneration and blood flow recovery in glaucoma. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42317267 | PubMed |
| 42132464 | Aqueous Humor Cytokine Profiles in Congenital Cataracts With Posterior Polar Abnormality and Associations With Postoperative Complications. | Invest Ophthalmol Vis Sci | 2026 | https://conductscience.org/library/papers/42132464 | PubMed |
| 42056940 | Serial aqueous VEGF analysis for predicting anti-VEGF treatment outcomes in neovascular glaucoma from diabetic retinopathy: a prospective analysis. | BMC Ophthalmol | 2026 | https://conductscience.org/library/papers/42056940 | PubMed |
| 41039289 | Neovascular glaucoma: comprehensive evaluation of etiology, treatment modalities, and visual prognosis. | BMC Ophthalmol | 2025 | https://conductscience.org/library/papers/41039289 | PubMed |
| 40583202 | Macular Edema in Diabetic Neovascular Glaucoma and Its Association with Systemic Diseases. | Korean J Ophthalmol | 2025 | https://conductscience.org/library/papers/40583202 | PubMed |
| 40540058 | Outcomes of glaucoma tube shunt implantation with vitrectomy in eyes with neovascular glaucoma. | Int Ophthalmol | 2025 | https://conductscience.org/library/papers/40540058 | PubMed |
| 39502628 | Surgical Outcomes of Mitomycin-C Augmented Trabeculectomy in Neovascular Glaucoma and Prognostic Factors for Surgical Failure in Thailand. | Clin Ophthalmol | 2024 | https://conductscience.org/library/papers/39502628 | PubMed |
| 37810031 | LncRNA MALAT1 knockdown inhibits the development of choroidal neovascularization. | Heliyon | 2023 | https://conductscience.org/library/papers/37810031 | PubMed |
| 37297954 | Increased Risk of Glaucoma in Patients with Rosacea: A Nationwide Population-Based Cohort Study. | J Clin Med | 2023 | https://conductscience.org/library/papers/37297954 | PubMed |
| 37010901 | Anti-vascular endothelial growth factor for neovascular glaucoma. | Cochrane Database Syst Rev | 2023 | https://conductscience.org/library/papers/37010901 | PubMed |
| 36060043 | A Long-term Clinical Study to Evaluate AGV with Concurrent Intravitreal Ranibizumab vs Primary AGV Implantation in Cases of Refractory Neovascular Glaucoma. | J Curr Glaucoma Pract | 2022 | https://conductscience.org/library/papers/36060043 | PubMed |
| 35727105 | Risk factors for ocular neovascularization after central retinal artery occlusion. | J Chin Med Assoc | 2022 | https://conductscience.org/library/papers/35727105 | PubMed |
| 35535041 | Study on Factors Associated with High Myopia CNV in Aqueous Humor and Serum. | Biomed Res Int | 2022 | https://conductscience.org/library/papers/35535041 | PubMed |
| 35136171 | Central retinal thickness changes and risk of neovascular glaucoma after intravitreal bevacizumab injection in patients with central retinal vein occlusion. | Sci Rep | 2022 | https://conductscience.org/library/papers/35136171 | PubMed |
| 34781913 | Quantitative analysis and clinical application of iris circulation in ischemic retinal disease. | BMC Ophthalmol | 2021 | https://conductscience.org/library/papers/34781913 | PubMed |
| 34650870 | Neovascular Glaucoma Progress and Impact of Therapeutic Intervention in Saudi Arabia. | Cureus | 2021 | https://conductscience.org/library/papers/34650870 | PubMed |
| 34575451 | From Oxidative Stress to Inflammation in the Posterior Ocular Diseases: Diagnosis and Treatment. | Pharmaceutics | 2021 | https://conductscience.org/library/papers/34575451 | PubMed |
| 34520511 | AAV-Mediated Expression of Human VEGF, TNF-α, and IL-6 Induces Retinal Pathology in Mice. | Transl Vis Sci Technol | 2021 | https://conductscience.org/library/papers/34520511 | PubMed |
| 34279462 | Expression of Vascular Endothelial Growth Factor-C in the Trabecular Meshwork of Patients with Neovascular Glaucoma and Primary Open-Angle Glaucoma. | J Clin Med | 2021 | https://conductscience.org/library/papers/34279462 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| VEGFA | 7422 | PubTator's text mining | https://conductscience.org/library/genes/7422 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9479280
GET https://conductscience.org/api/papers/v1/9479280/cited_by?page=2